|
|
|
|
|
|
by capableweb
2426 days ago
|
|
|
This seems to be the latest news on it: > In August 2019, the Democratic Republic of the Congo’s national health authorities, the World Health Organization, and the National Institutes of Health announced that they would stop using ZMapp, along with all other Ebola treatments except REGN-EB3 and mAb114, in their ongoing clinical trials, citing the higher mortality rates of patients not treated with REGN-EB3 and mAb114 From https://en.wikipedia.org/wiki/ZMapp#Use_during_the_2014%E2%8... So seems it's just used in some cases today. |
|
|